Chromium enhances insulin responsiveness via AMPK

Journal of Nutritional Biochemistry

Volumn 25, Issue 5, 2014, Pages 565-572

  Hoffman, Nolan J ^a   Penque, Brent A ^a   Habegger, Kirk M ^a,b   Sealls, Whitney ^a   Tackett, Lixuan ^a   Elmendorf, Jeffrey S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

AMP activated protein kinase; Cholesterol; Chromium; GLUT4; Insulin

Indexed keywords

CHOLESTEROL; CHROMIUM; F ACTIN; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; PICOLINIC ACID; SMALL INTERFERING RNA; TRACE ELEMENT; ACTIN; GLUCOSE; PICOLINIC ACID DERIVATIVE; SLC2A4 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; LIPID STORAGE; MYOTUBE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSPORT KINETICS; ANIMAL; CELL CULTURE; CYTOLOGY; DIET SUPPLEMENTATION; DRUG EFFECTS; HYPERINSULINISM; METABOLISM;

ACTINS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CHOLESTEROL; CHROMIUM; DIETARY SUPPLEMENTS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HYPERINSULINISM; INSULIN; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; PICOLINIC ACIDS; RATS; SIGNAL TRANSDUCTION;

EID: 84897940484     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.01.007     Document Type: Article

References (54)

1. Balk E.M., Tatsioni A., Lichtenstein A.H., Lau J., Pittas A.G. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care 2007, 30:2154-2163.
2. Chen G., Liu P., Pattar G.R., Tackett L., Bhonagiri P., Strawbridge A.B., et al. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3 T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol 2006, 20:857-870.
3. Pattar G.R., Tackett L., Liu P., Elmendorf J.S. Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutat Res 2006, 610:93-100.
4. Habegger K.M., Penque B.A., Sealls W., Tackett L., Bell L.N., Blue E.K., et al. Fat-induced membrane cholesterol accrual provokes cortical filamentous actin destabilisation and glucose transport dysfunction in skeletal muscle. Diabetologia 2012, 55:457-467.
5. Bhonagiri P., Pattar G.R., Habegger K.M., McCarthy A.M., Tackett L., Elmendorf J.S. Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance. Endocrinology 2011, 152:3373-3384.
6. Penque B.A., Hoggatt A.M., Herring B.P., Elmendorf J.S. Hexosamine biosynthesis impairs insulin action via a cholesterolgenic response. Mol Endocrinol 2013, 27:536-547.
7. Brozinick J.T., Hawkins E.D., Strawbridge A.B., Elmendorf J.S. Disruption of cortical actin in skeletal muscle demonstrates an essential role of the cytoskeleton in glucose transporter 4 translocation in insulin-sensitive tissues. J Biol Chem 2004, 279:40699-40706.
8. McCarthy A.M., Spisak K.O., Brozinick J.T., Elmendorf J.S. Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs GLUT4 vesicle trafficking and glucose transport. Am J Physiol Cell Physiol 2006, 291:C860-C868.
9. Ferrannini E., Smith J.D., Cobelli C., Toffolo G., Pilo A., DeFronzo R.A. Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest 1985, 76:357-364.
10. DeFronzo R.A., Gunnarsson R., Bjorkman O., Olsson M., Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 1985, 76:149-155.
11. Sealls W., Penque B.A., Elmendorf J.S. Evidence that chromium modulates cellular cholesterol homeostasis and ABCA1 functionality impaired by hyperinsulinemia-brief report. Arterioscler Thromb Vasc Biol 2011, 31:1139-1140.
12. Wang Y.Q., Dong Y., Yao M.H. Chromium picolinate inhibits resistin secretion in insulin-resistant 3 T3-L1 adipocytes via activation of amp-activated protein kinase. Clin Exp Pharmacol Physiol 2009, 36:843-849.
13. Zhao P., Wang J., Ma H., Xiao Y., He L., Tong C., et al. A newly synthetic chromium complex-chromium (D-phenylalanine)3 activates AMP-activated protein kinase and stimulates glucose transport. Biochem Pharmacol 2009, 77:1002-1010.
14. Penumathsa S.V., Thirunavukkarasu M., Samuel S.M., Zhan L., Maulik G., Bagchi M., et al. Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury. Biochim Biophys Acta 2009, 1792:39-48.
15. Thirunavukkarasu M., Penumathsa S.V., Juhasz B., Zhan L., Cordis G., Altaf E., et al. Niacin-bound chromium enhances myocardial protection from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006, 291:H820-H826.
16. Vinson J.A. So many choices, so what's a consumer to do?: a commentary on "Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats". Free Radic Biol Med 2007, 43:1121-1123.
17. Habegger K.M., Hoffman N.J., Ridenour C.M., Brozinick J.T., Elmendorf J.S. AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol. Endocrinology 2012, 153:2130-2141.
18. Chen G., Raman P., Bhonagiri P., Strawbridge A.B., Pattar G.R., Elmendorf J.S. Protective effect of phosphatidylinositol 4,5-bisphosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3 T3-L1 adipocytes to insulin. J Biol Chem 2004, 279:39705-39709.
19. Wang Z.Q., Zhang X.H., Russell J.C., Hulver M., Cefalu W.T. Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. J Nutr 2006, 136:415-420.
20. Brautigan D.L., Kruszewski A., Wang H. Chromium and vanadate combination increases insulin-induced glucose uptake by 3 T3-L1 adipocytes. Biochem Biophys Res Commun 2006, 347:769-773.
21. Wang H., Kruszewski A., Brautigan D.L. Cellular chromium enhances activation of insulin receptor kinase. Biochemistry 2005, 44:8167-8175.
22. Ducommun S., Wang H.Y., Sakamoto K., MacKintosh C., Chen S. Thr649Ala-AS160 knock-in mutation does not impair contraction/AICAR-induced glucose transport in mouse muscle. Am J Physiol Endocrinol Metab 2012, 302:E1036-E1043.
23. Chen S., Murphy J., Toth R., Campbell D.G., Morrice N.A., Mackintosh C. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J 2008, 409:449-459.
24. Pehmoller C., Treebak J.T., Birk J.B., Chen S., Mackintosh C., Hardie D.G., et al. Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. Am J Physiol Endocrinol Metab 2009, 297:E665-E675.
25. Szekeres F., Chadt A., Tom R.Z., Deshmukh A.S., Chibalin A.V., Bjornholm M., et al. The Rab-GTPase-activating protein TBC1D1 regulates skeletal muscle glucose metabolism. Am J Physiol Endocrinol Metab 2012, 303:E524-E533.
26. Hoffman N.J., Elmendorf J.S. Signaling, cytoskeletal and membrane mechanisms regulating GLUT4 exocytosis. Trends Endocrinol Metab 2011, 22:110-116.
27. Treebak J.T., Taylor E.B., Witczak C.A., An D., Toyoda T., Koh H.J., et al. Identification of a novel phosphorylation site on TBC1D4 regulated by AMP-activated protein kinase in skeletal muscle. Am J Physiol Cell Physiol 2010, 298:C377-C385.
28. Wang Y.Q., Yao M.H. Effects of chromium picolinate on glucose uptake in insulin-resistant 3 T3-L1 adipocytes involve activation of p38 MAPK. J Nutr Biochem 2009, 20:982-991.
29. Wang Y., Van Oort M.M., Yao M., Van der Horst D.J., Rodenburg K.W. Insulin and chromium picolinate induce translocation of CD36 to the plasma membrane through different signaling pathways in 3 T3-L1 adipocytes, and with a differential functionality of the CD36. Biol Trace Elem Res 2011, 142:735-747.
30. Qiao W., Peng Z., Wang Z., Wei J., Zhou A. Chromium improves glucose uptake and metabolism through upregulating the mRNA levels of IR, GLUT4, GS, and UCP3 in skeletal muscle cells. Biol Trace Elem Res 2009, 131:133-142.
31. Hardie D.G., Sakamoto K. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 2006, 21:48-60.
32. Wiernsperger N.F. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes. Diabetes Metab 1999, 25:110-127.
33. Muller S., Denet S., Candiloros H., Barrois R., Wiernsperger N., Donner M., et al. Action of metformin on erythrocyte membrane fluidity in vitro and in vivo. Eur J Pharmacol 1997, 337:103-110.
34. Matthaei S., Reibold J.P., Hamann A., Benecke H., Haring H.U., Greten H., et al. In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes. Endocrinology 1993, 133:304-311.
35. Fischer Y., Thomas J., Rosen P., Kammermeier H. Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats. Endocrinology 1995, 136:412-420.
36. Hundal H.S., Ramlal T., Reyes R., Leiter L.A., Klip A. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology 1992, 131:1165-1173.
37. Klip A., Guma A., Ramlal T., Bilan P.J., Lam L., Leiter L.A. Stimulation of hexose transport by metformin in L6 muscle cells in culture. Endocrinology 1992, 130:2535-2544.
38. Ciaraldi T.P., Kong A.P., Chu N.V., Kim D.D., Baxi S., Loviscach M., et al. Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects. Diabetes 2002, 51:30-36.
39. Thomas C.R., Turner S.L., Jefferson W.H., Bailey C.J. Prevention of dexamethasone-induced insulin resistance by metformin. Biochem Pharmacol 1998, 56:1145-1150.
40. Handberg A., Kayser L., Hoyer P.E., Voldstedlund M., Hansen H.P., Vinten J. Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats. Diabetologia 1993, 36:481-486.
41. Rouru J., Koulu M., Peltonen J., Santti E., Hanninen V., Pesonen U., et al. Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats. Br J Pharmacol 1995, 115:1182-1187.
42. Cefalu W.T., Wang Z.Q., Zhang X.H., Baldor L.C., Russell J.C. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 2002, 132:1107-1114.
43. Morris B., Gray T., MacNeil S. Evidence for chromium acting as an essential trace element in insulin-dependent glucose uptake in cultured mouse myotubes. J Endocrinol 1995, 144:135-141.
44. Goto Y., Kida K. Insulin-like action of chromate on glucose transport in isolated rat adipocytes. Jpn J Pharmacol 1995, 67:365-368.
45. Czech M.P. Insulin action and the regulation of hexose transport. Diabetes 1980, 29:399-409.
46. Pilch P.F., Thompson P.A., Czech M.P. Coordinate modulation of D-glucose transport activity and bilayer fluidity in plasma membranes derived from control and insulin-treated adipocytes. Proc Natl Acad Sci U S A 1980, 77:915-918.
47. Whitesell R.R., Regen D.M., Beth A.H., Pelletier D.K., Abumrad N.A. Activation energy of the slowest step in the glucose carrier cycle: break at 23 degrees C and correlation with membrane lipid fluidity. Biochemistry 1989, 28:5618-5625.
48. Tang L.Q., Wei W., Chen L.M., Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 2006, 108:109-115.
49. Turner N., Li J.Y., Gosby A., To S.W., Cheng Z., Miyoshi H., et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 2008, 57:1414-1418.
50. Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006, 55:2256-2264.
51. Kim E.J., Jung S.N., Son K.H., Kim S.R., Ha T.Y., Park M.G., et al. Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP-activated protein kinase. Mol Pharmacol 2007, 72:62-72.
52. Han S.H., Quon M.J., Koh K.K. Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptor-alpha activators. Hypertension 2005, 46:1086-1092.
53. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004, 53(Suppl. 1):S43-S50.
54. Khayat Z.A., Tsakiridis T., Ueyama A., Somwar R., Ebina Y., Klip A. Rapid stimulation of glucose transport by mitochondrial uncoupling depends in part on cytosolic Ca2+ and cPKC. Am J Physiol 1998, 275:C1487-C1497.